Ranbaxy launches generic version of Evoxac in US

Ranbaxy has launched generic cevimeline hydrochloride capsules, used in treating Sjogren's syndrome, in the US market. (Source: The Economic Times Healthcare and Biotech News)

Source: http://www.medworm.com/index.php?rid=6580307&cid=u_0_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Franbaxy-launches-generic-version-of-evoxac-in-us-market%2Farticleshow%2F16737820.cms

phlebotomy training nyc phlebotomy training in nyc phlebotomy training in va